Replies to post #57863 on Biotech Values

[ghmm]

In Toronto (COM.TO) it was down about 16%. Seems it was down a lot more at the open
http://finance.yahoo.com/q?s=COM.TO
Someone with more confidence could get a good buying opportunity as there is a recent precedent for a delay and approval. Kuvan (BMRN) got a couple week delay and then approved but then again the company was very clear in a conference call to say it was just a scheduling delay and was in label discussions (didn't see any such mention in today's PR)